• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A survey of diagnosis and therapy of inborn errors of immunity among practice-based physicians and clinic-based pneumologists and hemato-oncologists.

作者信息

Lehrnbecher Thomas, Russo Alexandra, Rohde Gernot

机构信息

Department of Pediatrics, Division of Hematology, Oncology and Hemostaseology, Johann Wolfgang Goethe University, Frankfurt/Main, Germany.

Department of Pediatric Hematology/Oncology, Center for Pediatric and Adolescent Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.

出版信息

Front Immunol. 2025 Jun 5;16:1597635. doi: 10.3389/fimmu.2025.1597635. eCollection 2025.

DOI:10.3389/fimmu.2025.1597635
PMID:40539071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12177555/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/8446780b7eb9/fimmu-16-1597635-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/a3a5d81f80ab/fimmu-16-1597635-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/3dd73f244281/fimmu-16-1597635-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/777bf0afc862/fimmu-16-1597635-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/e3b3ad82b5f3/fimmu-16-1597635-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/6f729048a51b/fimmu-16-1597635-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/92d214dd684c/fimmu-16-1597635-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/8446780b7eb9/fimmu-16-1597635-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/a3a5d81f80ab/fimmu-16-1597635-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/3dd73f244281/fimmu-16-1597635-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/777bf0afc862/fimmu-16-1597635-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/e3b3ad82b5f3/fimmu-16-1597635-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/6f729048a51b/fimmu-16-1597635-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/92d214dd684c/fimmu-16-1597635-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/12177555/8446780b7eb9/fimmu-16-1597635-g007.jpg

相似文献

1
A survey of diagnosis and therapy of inborn errors of immunity among practice-based physicians and clinic-based pneumologists and hemato-oncologists.针对基层医生、临床肺科医生和血液肿瘤学家开展的先天性免疫缺陷病诊断与治疗情况调查。
Front Immunol. 2025 Jun 5;16:1597635. doi: 10.3389/fimmu.2025.1597635. eCollection 2025.
2
Correction: A survey of diagnosis and therapy of inborn errors of immunity among practice-based physicians and clinic-based pneumologists and hemato-oncologists.更正：一项针对基层医生以及临床呼吸科医生和血液肿瘤学家的免疫缺陷病诊断与治疗的调查。
Front Immunol. 2025 Aug 7;16:1666329. doi: 10.3389/fimmu.2025.1666329. eCollection 2025.
3
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist.如何在患有恶性肿瘤的儿童中识别先天性免疫缺陷：儿科血液肿瘤学家的指南。
Pediatr Hematol Oncol. 2023 Mar;40(2):131-146. doi: 10.1080/08880018.2022.2085830. Epub 2022 Aug 1.
4
COVID-19 infection in inborn errors of immunity and their phenocopies: a systematic review and meta-analysis.先天性免疫缺陷及其表型模拟中的新型冠状病毒肺炎感染：一项系统评价和荟萃分析。
Infect Dis (Lond). 2025 Jun;57(6):483-517. doi: 10.1080/23744235.2025.2483339. Epub 2025 Apr 3.
5
Autoimmune manifestations in children with inborn errors of immunity in Morocco: A study from the national registry.摩洛哥先天性免疫缺陷患儿的自身免疫表现：一项来自国家登记处的研究。
J Transl Autoimmun. 2025 Jun 26;11:100299. doi: 10.1016/j.jtauto.2025.100299. eCollection 2025 Dec.
6
Genetic landscape of Romanian children with inborn errors of immunity via gene panels, exome, and genome sequencing.通过基因检测板、外显子组和基因组测序对罗马尼亚患有先天性免疫缺陷的儿童进行基因分析。
Sci Rep. 2025 May 29;15(1):18830. doi: 10.1038/s41598-025-03492-9.
7
Inborn errors of immunity and its clinical significance in children with lymphoma in China: a single-center study.中国儿童淋巴瘤中先天性免疫缺陷及其临床意义：一项单中心研究。
J Pediatr (Rio J). 2024 Jul-Aug;100(4):384-391. doi: 10.1016/j.jped.2024.02.002. Epub 2024 Mar 25.
8
Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series.以淋巴细胞增殖为表现的先天性免疫缺陷：来自一组病例的经验教训
Ann Hematol. 2025 Jun 24. doi: 10.1007/s00277-025-06456-1.
9
Endocrinopathies in children with inborn errors of immunity: a single-center experience.免疫缺陷病患儿的内分泌疾病：单中心经验
J Pediatr Endocrinol Metab. 2025 Apr 25;38(7):735-742. doi: 10.1515/jpem-2024-0593. Print 2025 Jul 28.
10
Future Directions in the Diagnosis and Treatment of APDS and IEI: a Survey of German IEI Centers.未来在 APDS 和 IEI 的诊断和治疗中的方向：德国 IEI 中心的调查。
Front Immunol. 2023 Oct 5;14:1279652. doi: 10.3389/fimmu.2023.1279652. eCollection 2023.

本文引用的文献

1
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET.活化磷脂酰肌醇3激酶δ综合征2的阴暗面：通过氟代脱氧葡萄糖正电子发射断层扫描改写的故事
J Clin Med. 2024 Apr 11;13(8):2203. doi: 10.3390/jcm13082203.
2
Immunoglobulin replacement therapies in inborn errors of immunity: a review.免疫球蛋白替代疗法在先天性免疫缺陷病中的应用：综述
Front Pediatr. 2024 Feb 15;12:1368755. doi: 10.3389/fped.2024.1368755. eCollection 2024.
3
Rescuing the cytolytic function of APDS1 patient T cells via TALEN-mediated PIK3CD gene correction.
通过TALEN介导的PIK3CD基因校正挽救APDS1患者T细胞的细胞溶解功能。
Mol Ther Methods Clin Dev. 2023 Oct 10;31:101133. doi: 10.1016/j.omtm.2023.101133. eCollection 2023 Dec 14.
4
Inborn errors of immunity: an expanding universe of disease and genetic architecture.先天性免疫缺陷：疾病和遗传结构不断扩大的领域。
Nat Rev Genet. 2024 Mar;25(3):184-195. doi: 10.1038/s41576-023-00656-z. Epub 2023 Oct 20.
5
Precision medicine: The use of tailored therapy in primary immunodeficiencies.精准医学：原发性免疫缺陷病的靶向治疗。
Front Immunol. 2022 Dec 8;13:1029560. doi: 10.3389/fimmu.2022.1029560. eCollection 2022.
6
Gene therapy for inborn errors of immunity: past, present and future.免疫缺陷性遗传病的基因治疗：过去、现在和未来。
Nat Rev Immunol. 2023 Jun;23(6):397-408. doi: 10.1038/s41577-022-00800-6. Epub 2022 Nov 25.
7
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome.一项针对激活的 PI3Kδ 综合征的 PI3Kδ 抑制剂 leniolisib 的随机、安慰剂对照 3 期试验。
Blood. 2023 Mar 2;141(9):971-983. doi: 10.1182/blood.2022018546.
8
The lung in inborn errors of immunity: From clinical disease patterns to molecular pathogenesis.先天性免疫缺陷中的肺部疾病：从临床疾病模式到分子发病机制。
J Allergy Clin Immunol. 2022 Dec;150(6):1314-1324. doi: 10.1016/j.jaci.2022.08.024. Epub 2022 Oct 14.
9
Immunosuppression in Patients With Primary Immunodeficiency-Walking the Line.原发性免疫缺陷患者的免疫抑制——把握分寸
J Allergy Clin Immunol Pract. 2022 Dec;10(12):3088-3096. doi: 10.1016/j.jaip.2022.08.025. Epub 2022 Aug 29.
10
Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.外周血细胞减少症，先天性免疫缺陷的早期指标。
Br J Haematol. 2022 Sep;198(5):875-886. doi: 10.1111/bjh.18337. Epub 2022 Jul 6.